Dailypharm Live Search Close

Kyprolis succeeded in renewing the RSA contract

By Kim, Jung-Ju | translator Choi HeeYoung

21.12.21 06:00:38

°¡³ª´Ù¶ó 0
The price of Eutropin is reduced to PVA

Promotion of the MOHW's Amendment of the Drug Benefit List and the Upper Limit Table (Draft)

LG Chem's Eutropin Plus 24mg (Human Growth Hormone, Somatropin) and Eutropin Pen are included in the PVA, falling from as little as 1% to as much as 4%. In addition, Amgen Korea's Kyprolis 60mg (Carfilzomib) and Kyprolis 30mg will be adjusted to 4-5% lower prices, respectively, after successfully renewing their RSA contracts.



According to the industry, until recently, these companies agreed to cut insurance prices through negotiations with the NHIS and the PVA to renew their contracts with RSA. Based on this, the MOHW is pushing for a revision of the "drug benefit list and upper limit table." If the revision is finalized soon, it will be applied as of January 1.

First, the price of Eutrop

Kim, Jung-Ju(jj0831@dailypharm.com)
If you want to see the full article, please JOIN US (click)